Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.012 SGD | -.--% | -.--% | +9.09% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 33.84 | 16.03 | 16.03 | 24.93 | 23.15 | 19.59 |
Enterprise Value (EV) 1 | 35.1 | 16.53 | 16.17 | 23.89 | 23.19 | 17.25 |
P/E ratio | -7.85 x | -2.72 x | -3.75 x | -11 x | -15.4 x | -64 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 1.73 x | 0.67 x | 1.37 x | 1.24 x | 1.07 x | 0.98 x |
EV / Revenue | 1.79 x | 0.69 x | 1.38 x | 1.19 x | 1.07 x | 0.86 x |
EV / EBITDA | 13.6 x | 4.3 x | 17.2 x | 13.5 x | 17.6 x | 8.96 x |
EV / FCF | 3.84 x | 1.24 x | 25.7 x | 15 x | 49.1 x | 9.85 x |
FCF Yield | 26.1% | 80.7% | 3.9% | 6.68% | 2.04% | 10.1% |
Price to Book | 0.56 x | 0.29 x | 0.32 x | 0.52 x | 0.5 x | 0.42 x |
Nbr of stocks (in thousands) | 1,780,854 | 1,780,861 | 1,780,861 | 1,780,861 | 1,780,861 | 1,780,861 |
Reference price 2 | 0.0190 | 0.009000 | 0.009000 | 0.0140 | 0.0130 | 0.0110 |
Announcement Date | 4/12/19 | 4/14/20 | 4/13/21 | 4/12/22 | 4/12/23 | 4/11/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 19.59 | 23.9 | 11.7 | 20.07 | 21.59 | 20.03 |
EBITDA 1 | 2.585 | 3.842 | 0.9393 | 1.763 | 1.317 | 1.925 |
EBIT 1 | -0.9334 | -0.4468 | -3.567 | -2.71 | -2.376 | -1.649 |
Operating Margin | -4.76% | -1.87% | -30.5% | -13.5% | -11% | -8.23% |
Earnings before Tax (EBT) 1 | -1.732 | -5.888 | -4.809 | -3.022 | -1.781 | -0.6055 |
Net income 1 | -5.67 | -5.902 | -4.236 | -2.272 | -1.505 | -0.307 |
Net margin | -28.94% | -24.7% | -36.22% | -11.32% | -6.97% | -1.53% |
EPS 2 | -0.002421 | -0.003314 | -0.002399 | -0.001275 | -0.000844 | -0.000172 |
Free Cash Flow 1 | 9.148 | 13.34 | 0.6303 | 1.595 | 0.4719 | 1.751 |
FCF margin | 46.69% | 55.83% | 5.39% | 7.94% | 2.19% | 8.74% |
FCF Conversion (EBITDA) | 353.92% | 347.25% | 67.1% | 90.45% | 35.83% | 90.95% |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 4/12/19 | 4/14/20 | 4/13/21 | 4/12/22 | 4/12/23 | 4/11/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 1.26 | 0.5 | 0.14 | - | 0.04 | - |
Net Cash position 1 | - | - | - | 1.04 | - | 2.33 |
Leverage (Debt/EBITDA) | 0.4893 x | 0.1308 x | 0.1503 x | - | 0.0283 x | - |
Free Cash Flow 1 | 9.15 | 13.3 | 0.63 | 1.59 | 0.47 | 1.75 |
ROE (net income / shareholders' equity) | -2.93% | -10.3% | -8.12% | -4.67% | -3.2% | -0.7% |
ROA (Net income/ Total Assets) | -0.61% | -0.34% | -3.01% | -2.46% | -2.2% | -1.57% |
Assets 1 | 929.1 | 1,752 | 140.9 | 92.47 | 68.4 | 19.53 |
Book Value Per Share 2 | 0.0300 | 0.0300 | 0.0300 | 0.0300 | 0.0300 | 0.0300 |
Cash Flow per Share 2 | 0 | 0 | 0 | 0 | 0 | 0 |
Capex 1 | 0.25 | 0.01 | 0.06 | 0.37 | 1.66 | 0.41 |
Capex / Sales | 1.29% | 0.04% | 0.48% | 1.86% | 7.7% | 2.06% |
Announcement Date | 4/12/19 | 4/14/20 | 4/13/21 | 4/12/22 | 4/12/23 | 4/11/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+9.09% | 15.67M | |
+16.90% | 47.3B | |
+1.22% | 15.66B | |
-5.19% | 15.27B | |
-14.69% | 10.57B | |
+23.60% | 8.64B | |
-3.59% | 7.71B | |
+105.28% | 7.91B | |
-8.03% | 7.4B | |
+22.95% | 6.7B |
- Stock Market
- Equities
- 5GZ Stock
- Financials HGH Holdings Ltd.